Imagine a world where your smartwatch doesn’t just count steps or track sleep—it could actually warn you about a silent killer like hypertension. That future might be closer than you think for Pixel Watch users. Fitbit Labs is reportedly on the brink of introducing Apple Watch-like hypertension alerts, but there’s a twist: they’re taking a bold, experimental approach that’s sparking both excitement and questions. Here’s the full story—and why it matters.
But here’s where it gets controversial... While Apple’s hypertension detection system has already made waves with its Watch Series 11, Fitbit is taking a different path. According to a 9to5Google report, Fitbit’s Hypertension Lab is testing two experimental features exclusively on the Pixel Watch 3. Yes, you read that right—this year’s model is left out of the study, leaving some users wondering why. The goal? To use Pixel Watch data to spot early signs of high blood pressure, potentially saving lives. But with such a limited scope, is this a step forward or a missed opportunity?
Here’s how it works: Fitbit is recruiting up to 10,000 participants across the U.S. to wear their Pixel Watch 3 as usual for 180 days. Some will also receive an Ambulatory Blood Pressure Monitoring (ABPM) cuff to wear for 24 hours, along with a $25 gift card as a thank-you. And this is the part most people miss... While the study promises to refine hypertension alerts, it also hints at a broader trend: smartwatches are becoming less about fitness and more about serious health monitoring. But is this a blessing or a curse? Could over-reliance on these alerts lead to unnecessary anxiety or missed diagnoses?
Apple’s system, for instance, uses the Watch’s optical heart sensor to track blood vessel responses over 30 days, flagging potential hypertension issues. Fitbit’s approach might mirror this, but details are still under wraps. Meanwhile, Fitbit’s Unusual Trend Detection feature—another experimental addition—aims to give users a heads-up when their health metrics deviate from the norm. Think of it as a personal health assistant, but with a catch: users must log possible causes for the changes, which could feel like extra work for some.
Here’s the bigger question... As smartwatches inch closer to medical devices, who’s responsible for ensuring accuracy and safety? Is it the tech companies, regulators, or users themselves? Fitbit’s study is a step in the right direction, but it’s just the beginning. What do you think? Are hypertension alerts a game-changer, or are we handing too much power to our wrists? Let’s debate in the comments—your take could shape the future of wearable health tech.
